Related Experiment Video
Updated: Feb 27, 2026
10:35
Stereotactic Radiosurgery for Gynecologic Cancer
Published on: April 17, 2012
18.8K
HOTAIR: a key regulator in gynecologic cancers
Jing Li1, Jing Wang2, Yan Zhong3
1Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052 China.
Cancer Cell International
|June 27, 2017
Summary
Long non-coding RNA HOTAIR is implicated in gynecologic cancers. This review summarizes HOTAIR's roles in promoting tumor invasion and metastasis, highlighting its deregulation in various cancers.
Area of Science:
- Molecular Biology
- Genetics
- Oncology
Background:
- Long non-coding RNAs (lncRNAs) are key regulators in cancer development.
- HOTAIR (HOX transcript antisense RNA) is an lncRNA associated with the HOXC gene cluster.
- HOTAIR interacts with epigenetic modifiers like PRC2 and LSD1/CoREST/REST complexes.
Purpose of the Study:
- To review the critical roles of HOTAIR in gynecologic cancers.
- To summarize recent findings on HOTAIR's function in cancer initiation and progression.
- To elucidate the mechanisms underlying HOTAIR's involvement in gynecologic malignancies.
Main Methods:
- Literature review of studies on HOTAIR and gynecologic cancers.
- Analysis of HOTAIR's molecular interactions and epigenetic regulatory functions.
- Synthesis of data on HOTAIR's impact on tumor invasion, metastasis, and gene expression.
Main Results:
- HOTAIR is frequently deregulated in various human cancers, including gynecologic cancers.
- HOTAIR promotes tumor invasion and metastasis by silencing tumor suppressors and activating oncogenes.
- HOTAIR influences oncogenic signaling pathways, contributing to cancer progression.
Conclusions:
- HOTAIR plays a significant role in the pathogenesis of gynecologic cancers.
- Understanding HOTAIR's mechanisms is crucial for developing targeted cancer therapies.
- Further research is needed to fully elucidate HOTAIR's functions and therapeutic potential in oncology.
More Related Videos
09:23Inducing Targeted Mild Hyperthermia in Murine Tumor Models through Photothermal Conversion of Near-infrared Light by Intratumoral Gold Nanorods
Published on: October 10, 2025
1.6K
11:44Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
Published on: March 30, 2019
8.1K
Related Concept Videos
01:30Hormonal Control of the Ovarian Cycle
7.2K
The ovarian cycle is meticulously regulated by the hypothalamic-pituitary-gonadal axis. This cycle orchestrates the release of a mature oocyte, essential for reproduction.
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
7.2K
02:49Cancer Therapies
10.3K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.3K
02:57Targeted Cancer Therapies
9.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.0K
01:40Hormonal Regulation
49.0K
Hormones regulate a significant portion of digestion through activation of the neuroendocrine system. The neuroendocrine system of digestion contains many different hormones all with multiple functions that are both, directly and indirectly, involved in digestion.
49.0K
01:33Hormonal Regulation
36.5K
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
36.5K
01:24Regulation of Angiogenesis and Blood Supply
3.8K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.8K